Scholarlink

<p>Parkinson’s disease (PD) is increasingly viewed as both a neurological and metabolic disorder, with the gut-brain axis playing a key role. This study explored how polystyrene (PS) nanoplastics contributed to PD progression by examining their metabolic impact in an A53T α-synuclein (αS) mouse model. Mice given PS nanoplastics orally (2 mg/kg every other day for three months) displayed compromised gut barrier integrity, including a 30% drop in goblet cells and increased epithelial apoptosis in the ileum. Microbial diversity in the ileum rose sharply, with an overgrowth of <i>Desulfovibrio spp</i>. linked to neuroinflammation and αS aggregation. KEGG analysis confirmed apoptosis and lipopolysaccharide biosynthesis pathways influenced by nanoplastics, while metabolomics identified over 200 altered fecal metabolites, including those associated with cytochrome P450 activity and disruptions to cancer-related pathways. Additionally, histopathology revealed liver inflammation, underscoring the systemic effects of nanoplastic exposure. Overall, our findings suggest that environmental nanoplastics may aggravate PD physiopathology through gut-liver axis disruption and metabolic dysregulation.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dysfunctional digestive tract highlights the metabolic hallmarks of nanoplastic-exacerbated Parkinson’s pathology

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月20日

查看全文
  • Xiufang Liang,
  • Yue Wang,
  • Nicholas Andrikopoulos,
  • Pu Chun Ke,
  • Yuhuan Li

摘要

Parkinson’s disease (PD) is increasingly viewed as both a neurological and metabolic disorder, with the gut-brain axis playing a key role. This study explored how polystyrene (PS) nanoplastics contributed to PD progression by examining their metabolic impact in an A53T α-synuclein (αS) mouse model. Mice given PS nanoplastics orally (2 mg/kg every other day for three months) displayed compromised gut barrier integrity, including a 30% drop in goblet cells and increased epithelial apoptosis in the ileum. Microbial diversity in the ileum rose sharply, with an overgrowth of Desulfovibrio spp. linked to neuroinflammation and αS aggregation. KEGG analysis confirmed apoptosis and lipopolysaccharide biosynthesis pathways influenced by nanoplastics, while metabolomics identified over 200 altered fecal metabolites, including those associated with cytochrome P450 activity and disruptions to cancer-related pathways. Additionally, histopathology revealed liver inflammation, underscoring the systemic effects of nanoplastic exposure. Overall, our findings suggest that environmental nanoplastics may aggravate PD physiopathology through gut-liver axis disruption and metabolic dysregulation.